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Abstract
Background: Accumulation of senescent cells has been associated with pro-inflammatory effects with deleterious
consequences in different human diseases. The purpose of this study was to analyze cell senescence in human
synovial tissues (ST), and its impact on the pro-inflammatory function of synovial fibroblasts (SF).
Results: The expression of the senescence marker p16INK4a (p16) was analyzed by immunohistochemistry in
rheumatoid arthritis (RA), osteoarthritis (OA), and normal ST from variably aged donors. The proportion of p16(+)
senescent cells in normal ST from older donors was higher than from younger ones. Although older RA and OA ST
showed proportions of senescent cells similar to older normal ST, senescence was increased in younger RA ST
compared to age-matched normal ST. The percentage of senescent SA-β-gal(+) SF after 14 days in culture positively
correlated with donor’s age. Initial exposure to H2O2 or TNFα enhanced SF senescence and increased mRNA
expression of IL6, CXCL8, CCL2 and MMP3 and proteins secretion. Senescent SF show a heightened IL6, CXCL8 and
MMP3 mRNA and IL-6 and IL-8 protein expression response upon further challenge with TNFα. Treatment of
senescent SF with the senolytic drug fenofibrate normalized IL6, CXCL8 and CCL2 mRNA expression.
Conclusions: Accumulation of senescent cells in ST increases in normal aging and prematurely in RA patients.
Senescence of cultured SF is accelerated upon exposure to TNFα or oxidative stress and may contribute to the
pathogenesis of synovitis by increasing the production of pro-inflammatory mediators.
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Background
A common factor to aging associated diseases is a
chronic, low-grade inflammation, that has been termed
“inflammaging” [1, 2]. The cellular basis of this process
consists of a cellular pro-inflammatory phenotype, re-
ferred to as “senescence-associated secretory phenotype”
(SASP), characterized by enhanced production of cyto-
kines, chemokines and matrix metalloproteinases that
has been linked to cell senescence [3–5]. Senescent cells,
characterized by the expression of p16INK4a and
irreversible cell-cycle arrest, accumulate in tissues during
normal aging, and are thought to contribute to organ
dysfunction in different age-associated diseases [6–10].
This concept has been explored in osteoarthritis (OA), a
joint disease tightly linked to aging. Increased senescent
chondrocytes with a pro-inflammatory SASP phenotype
have been demonstrated in OA cartilage and their trans-
plant to normal joints induce joint damage similar to
OA [11–14]. Removal of senescent cells by transgenic
technology in an experimental OA model has also dem-
onstrated their deleterious effects, providing the basis for
senolysis as a potential therapy in OA [15].
The relationship between aging and arthritis is less
clear in other chronic inflammatory joint conditions
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such as rheumatoid arthritis (RA). Epidemiology of RA
shows that its incidence increases with aging, with the
sharpest incidence rise between the fourth and sixth de-
cades of life [16]. Aging of the T-cell compartment of
the immune system may favor autoimmunity, and this
mechanism has been proposed to explain the relation-
ship between aging and RA [17, 18]. However, the po-
tential participation of aging-associated cell changes in
the local synovial environment has not been studied.
Chronic inflammatory diseases are characterized by in-
creased oxidative stress and ROS production, one of the
most relevant contributors to the genomic and mito-
chondrial damage that characterizes the cellular aging
process. It is therefore expected that local cell aging be
present in the inflamed synovium. Tissue inflammation
and cell senescence have been shown to synergize in the
production of pro-inflammatory mediators such as IL-6
that, in turn, activates cellular reprogramming [19]. This
reprogramming is interpreted as an attempt to repair tis-
sue damage, but proof of this plasticity in synovitis or
other human inflammatory tissues is lacking.
The main resident cells in RA synovial tissue (ST) are
synovial fibroblasts (SF) which contribute to the patho-
genesis of arthritis by synthesizing a variety of mediators
that are very similar to those associated to the SASP,
notably IL-6, MMPs and chemokines [20]. Fibroblast
senescence has been observed in other normal aged tis-
sues and in pathological tissues such as cancer or fibro-
sis [21, 22]. In normal skin, fibroblast senescence has
been linked to aging and to the acquisition of a matrix
degradation and pro-inflammatory phenotype [8, 23].
Here, we describe the accumulation of senescent cells in
normal aged and arthritic ST and characterize the
phenotype of senescent SF.
Results
p16 and NANOG expression in ST
Nuclear expression of the p16 senescent marker was de-
tected by immunohistochemistry (IHC) in all OA, RA
and normal ST groups (Fig. 1a). The proportion of biop-
sies showing presence of p16(+) cells was higher in RA
(37/43, 86%) and OA (13/14, 92.9%) than in normal
groups (10/15, 66.7%). Consistent with the older age of
OA patients (69.9 ± 5.7 vs 40 ± 16.06 in control group
and 54.4 ± 14.3 in RA group), OA synovia showed a sig-
nificantly higher density of p16(+) cells (Fig. 1b). Since
the mean and median age of the healthy donor popula-
tion were 40 and 44 years old, respectively, we set up a
cut-off age of 40 years to dissect the contribution of age
to the abundance of p16 and NANOG. Expression of
p16 in normal ST was higher in old (age > 40 years old)
compared with young (age < 40 years old) donors. Youn-
ger RA patients showed a significant increase of p16(+)
cell density compared with age-matched healthy donors,
whereas older RA patients showed levels similar to the
normal controls group (Fig. 1c). Scattered senescent
p16(+) cells were observed both through lining and
sublining areas in all normal and OA/RA groups.
Double immunofluorescent (IF) labelling confirmed
that most p16(+) nuclei colocalized to hsp47(+) SF
[24] or CD68(+) macrophages (see in Additional file 1:
Figure S1).
Expression of the reprogramming marker NANOG,
previously shown associated to cell senescence [19], was
significantly increased in OA and RA groups compared
to normal ST (Fig. 1a and b). No age-related differences
in NANOG expression were observed in either normal
or in RA ST groups (Fig. 1c).
Cell senescence in cultured SF
Replicative senescence was induced in SF from healthy
donors after 14-day culture. Cultured SF usually reached
confluence at day 8 after seeding and at day 14 most SF
were arrested in G0/G1 phase but significant cell death
was not observed (data not shown). To determine the
proportion of senescent cells under these conditions in
the different groups we detected lysosomal β-
galactosidase activity [25, 26] (Fig. 2a). Frequency of SA-
β-gal(+) senescent cells in SF cultures increased propor-
tionally to the number of days in culture and was signifi-
cantly higher at day 14 than at day 5 of culture (Fig. 2b).
Under these conditions, we determined the proportion
of senescent cells in SF cultures obtained from differ-
ently aged healthy donors. The percentage of SA-β-
gal(+) cells in 14-day cultures positively correlated
with age (r = 0.75/p = 0.008) and was significantly
higher in old (> 40 years old) than in young healthy
SF (Fig. 2c and d). SF cultures from old arthritic pa-
tients (OA or RA) showed a proportion of SA-β-
gal(+) that was similar to the similarly aged (> 40
years old) group of healthy donors. Increased senes-
cence of old normal SF compared to younger coun-
terparts was confirmed by the mRNA expression of
additional markers of senescence, i. e., enhanced
CDKN1A and reduced LMNB1 [27, 28] (Fig. 2e).
To evaluate the influence of oxidative or inflammatory
stress on SF senescence we developed a model of stress-
induced senescence. To this aim, 14-day cultures of nor-
mal SF were briefly exposed to TNFα or H2O2 before
the onset of senescence (day 2 for TNFα, day 5 for
H2O2) and the presence of SA-β-gal(+) senescent cells
was analyzed at the end of the experiment. Both TNFα
and H2O2 significantly increased the proportion of sen-
escent SA-β-gal(+) in young SF. Analysis of old SF con-
firmed an elevated proportion of senescent cells in basal
conditions and showed that TNFα and H2O2 induced a
more limited increase, only significant upon H2O2 ex-
posure (Fig. 2f).
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Collectively, these results show that SF cultures from
younger individuals are highly susceptible to stress-
induced senescence, whereas SF from older individuals
show increased spontaneous senescence in 14-day
cultures.
Expression of SASP mediators by senescent SF
Next, we used the model of SF stress-induced senes-
cence as described above to analyze whether SF senes-
cence is also paralleled by increased expression of the
pro-inflammatory factors characteristic of the SASP.
We collected RNA and supernatants from control or
senescent SF induced by H2O2 or TNFα in 14-day cul-
tures. mRNA expression of the p16-encoding gene,
CDKN2A, and CDKN1A confirmed increased SF senes-
cence (Fig. 3a), and mRNA expression of pro-
inflammatory SASP-associated factors: IL6 and CXCL8,
monocyte recruitment chemokine CCL2 and matrix
metallopeptidase protein MMP3 were determined. All
these factors were up-regulated by TNFα- and, more
variably, by H2O2-induced senescence (Fig. 3b). These
findings were mirrored by a similar increase in the levels
of secreted IL-6 and IL-8 proteins in culture superna-
tants, also more consistently with TNFα (Fig. 3c).
Since the pro-inflammatory cytokine TNFα is a strong
short-term inducer of these factors in SF, we examined
the kinetics of cytokine expression upon TNFα treat-
ment to confirm that the observed late up-regulation of
inflammatory gene expression is associated to senes-
cence rather than to a persistent transcriptional response
to TNFα. Kinetics analysis indicated that expression of
IL6 and CXCL8 was comparable between control and
Fig. 1 Expression of p16 and NANOG in ST. a IHC detection of p16 and NANOG in normal, OA and RA ST (Bar 50 μm). b Density of p16(+) and
NANOG(+) cells in the different groups (*ANOVA). c Density of p16(+) and NANOG(+) cells in normal and RA ST stratified by age: under (< 40)
and over (> 40) 40 years old (*Mann-Whitney)
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TNFα senescent SF after 8 days in culture, started to in-
crease in TNFα-senescent cultures by day 11 in culture
and reached the peak expression by day 14, the endpoint
of senescent cultures. These findings rule out a direct
contribution of the early TNFα challenge to the late
SASP expression (see in Additional file 2: Figure S2).
These results indicate that stress-induced senescence
enhanced the expression of factors characteristic of the
SASP in SF, and that the up-regulation of the inflamma-
tory genes is temporally associated to the acquisition of
senescence rather than to persistent transcriptional ef-
fects. Under these circumstances, pharmacological tar-
geting of senescent cells can provide a therapeutic
opportunity to reduce senescence-associated inflamma-
tion. To test this hypothesis, we treated TNFα-induced
senescent SF for 72 h with fenofibrate, a PPARα agonist
recently been reported to have potent senolytic and
senomorphic activity in senescent chondrocytes and
tumour cell lines [29, 30]. Fenofibrate treatment of
TNFα-senescent SF provoked a reduction of CDKN2A
expression to levels comparable of control SF (Fig. 4).
Fenofibrate did not induce increased cell death as
assessed by microscopy or lactate dehydrogenase (LDH)
activity in supernatants, thus pointing to a senomorphic
rather that senolytic effect. This reduction in CDKN2A
expression was accompanied by a significant decrease in
the expression of IL6, CXCL8 and CCL2 but not that of
MMP3 (Fig. 4).
To model the potential impact of senescence on the
response of SF to the inflammatory environment of arth-
ritic joints, TNFα-induced senescent SF were stimulated
with a secondary challenge of TNFα for 24 h. TNFα re-
stimulation induced a significant increase in the
mRNA expression of the SASP components IL6,
CXCL8 and CCL2 in senescent compared to control
SF (Fig. 5a). Likewise, secretion of the cytokines IL-6
and IL-8 was enhanced in senescent SF after TNFα
treatment (Fig. 5b).
Collectively, these findings indicate that the response
of senescent SF to further inflammatory challenge is
heightened, so that senescence potentiates the expres-
sion and production of inflammatory mediators.
Discussion
Tissue accumulation of senescent cells has been identi-
fied as a deleterious factor that promotes inflammation
and tissue damage in different human diseases and ani-
mal models of aging related diseases. Regarding joint
diseases, evidence of this concept has been only provided
in human and experimental OA, with the main focus on
chondrocytes and cartilage damage. Human cartilage
and chondrocyte cultures from OA patients have shown
increased number of senescent cells that contribute to
cartilage degradation by increased IL-1, IL-6 and MMP-
3 expression [12, 14].
Fig. 2 Analysis of senescence in 14-day SF cultures. a SA-β-gal activity and DAPI staining. b Time-dependent expansion of SA-β-gal(+) in HSF
cultures (n = 4) (*ANOVA). c Correlation between the frequency of SA-β-gal(+) SF and donor’s age (n = 11). d Frequency of SA-β-gal(+) from < 40
(n = 5) and > 40 (n = 6) HSF, and from > 40 OASF (n = 4) and > 40 RASF (n = 4) cultures (*Mann-Whitney). e CDKN1A and LMNB1 mRNA expression
in < 40 (n = 3) and > 40 (n = 5) HSF cultures (*Mann-Whitney). f Frequency of SA-β-gal(+) from < 40 (n = 5) and > 40 (n = 6) HSF cultures treated
with TNFα, H2O2 or untreated (CT) (*Friedman, ##Mann-Whitney)
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We have studied cell senescence in variably aged nor-
mal ST and found an increased proportion of p16(+)
cells in aged donors in the absence of inflammatory
pathology, and at levels that parallel those observed in
similarly aged OA or RA tissues. Furthermore, cultured
normal SF exhibit levels of senescence that correlate
well with the age of the donors and that are also signifi-
cantly increased in the > 40 year-old group. Similar ob-
servations have previously been described in mouse and
human skin fibroblasts, where senescence was associ-
ated to defective repair and a pro-inflammatory SASP,
but its implications in skin disease have not been stud-
ied [31–33]. Lung fibrosis fibroblasts also show senes-
cent features and a profibrotic and SASP phenotype
that contributes to experimental lung fibrosis [22]. The
contribution of senescence of other cell lineages such
as macrophages, chondrocytes or cardiomyocytes, to
different aging pathologies such as arteriosclerosis, OA
or cardiomyopathy has also been demonstrated by
senolytic intervention in animal models [15, 34, 35]. Al-
though typical SASP cytokines and other pro-
inflammatory factors are commonly represented in dif-
ferent cell types, cell and tissue-specific differences
occur that may explain the different pathological conse-
quences of senescence such as defective repair, fibrosis
or inflammatory damage [36, 37].
Our observations suggest that synovial senescent SF
accumulation occurs progressively along normal aging,
from relatively early ages, and preceding the age of peak
prevalence of RA. Interestingly, in old OA or RA dis-
eased synovium no further increase was observed in the
proportion of p16 senescent cells or in ex vivo cultured
senescent SF compared to age-matched normal synovial
tissues. Only in RA synovium from young (< 40 years
old) individuals, an increased proportion of senescent
cells was observed. A potential limitation of our study is
that the number of control biopsies was relatively low
due to their origin, i. e., healthy donors, but the sample
size allowed statistical comparisons that showed signifi-
cant changes. Another limitation is the limited availabil-
ity of RA tissues from patients under 40 years-old. Only
histological samples but not SF cultures from patients
under this age were available.
We have also confirmed the capacity of oxidative
stress and TNFα to induce SF senescence ex vivo.
Therefore, SF senescence may be a consequence of in-
flammatory cell damage in younger RA patients but
could also be interpreted as premature synovial cell
aging preceding and contributing to RA development.
The observed senescent SF phenotype includes en-
hanced expression of typical SASP factors with relevant
roles in the pathogenesis of RA such as IL-6, IL-8, MCP-
1 and MMP-3, as well as an enhanced response to fur-
ther TNFα stimulation. In endothelial cells, a similar
Fig. 3 Analysis of senescent markers and SASP mediators in stress-
induced senescent SF. HSF in 14-day cultures subjected to stress-
induced senescence with H2O2 or TNFα. a Change in CDKN2A and
CDKN1A mRNA expression (n = 8). b Change in IL6, CXCL8, MMP3
and CCL2 mRNA expression (n = 12). c Change in IL-6 and IL-8
protein levels (n = 8). (*Wilcoxon test)
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positive feedback mechanism has been described by
which TNFα-mediated senescence activates the secretion
of factors that sustain senescence and cytokine produc-
tion via JAK/STAT pathway activation [38].
To further explore the potential of senolytic interven-
tion to reduce the expression of pro-inflammatory fac-
tors in SF, we treated senescent SF cultures with
fenofibrate, an agent that we found able to reduce cell
senescence in chondrocytes. Fenofibrate reduced the ex-
pression of the senescence marker CDKN2A in SF cul-
tures, confirming previous findings in tumour cell lines
[29], although the mechanism is still unclear since we
did not observe increased death in fenofibrate-treated
senescent SF. Such reduction of CDKN2A expression
was associated to a reduction of pro-inflammatory fac-
tors. Further studies are needed to confirm the relevance
of this process in the development and progression of
RA and to develop senescence based therapies.
Another process, mechanistically linked to senescence
and inflammation, is the activation of a reparative pro-
gram by reprograming cells with stem pluripotent cap-
acity. This has been explored in animal models by the
expression of the NANOG pluripotency marker. Mos-
teiro et al have elegantly described the link between sen-
escence and reprogramming, and proposed that the
senescent cells send signals to neighboring cells to pro-
mote reprogramming, with IL-6 being of particular rele-
vance [19]. Multilineage-differentiating NANOG(+) cells
have been isolated from human synovial tissues [39, 40].
Interestingly, we observed an increase of NANOG
expression in inflammatory OA and RA tissues com-
pared to control ST providing evidence of the link
between this factor and the inflammatory process.
However, in normal older tissues, in spite of the ac-
cumulation of senescent cells, NANOG expression
was not increased which suggests that higher inflam-
matory, i.e. IL-6, levels are required to activate repro-
gramming and regeneration.
In summary, our data describe the kinetics of senes-
cent SF accumulation in synovial tissue along normal
aging and in inflammatory joint disease, and confirm the
potential of these cells to contribute to the RA pathology
by producing inflammatory mediators.
Conclusions
This study provides evidence showing that senescent
cells accumulate in synovial tissues in normal aging and
prematurely in RA. We demonstrate that senescent SF
show enhanced pro-inflammatory and tissue-damaging
mediators that may contribute to the pathogenesis of
RA. Therefore, removal of senescent cells or senolytic
strategies could be a potential intervention to prevent or
reduce synovial inflammation in RA. This adds RA and
possibly other chronic arthritides to the group of dis-
eases associated to increased tissue cell senescence
where senolytic/senomorphic pharmacological interven-
tions should be further investigated.
Methods
Patients and synovial biopsies
ST were obtained by arthroscopic knee biopsies from
patients who fulfilled the American Rheumatism Associ-
ation revised criteria for RA (n = 43) [41]. All patients
had active disease characterized by inflammation of at
least one knee joint. OA synovial tissues were obtained
by synovectomy at prosthetic join replacement surgery
(n = 18) and histologically normal synovial tissues from
healthy individuals without joint disease at elective arth-
roscopy for minor traumatic lesions, excluding those tis-
sues with significant inflammatory cell infiltration (n =
15). All patients signed a written informed consent, and
the study was approved by ethics committees of Hospital
Clinic, Barcelona, and Hospital 12 de Octubre, Madrid
(N° CEI:17/085).
Fig. 4 Effect of fenofibrate treatment in TNFα-induced senescent SF. 14-day senescent (SEN) and control (CT) SF were treated with fenofibrate
(FB, 25 μM) for 72 h. Graphics show the changes in CDKN2A and SASP factors IL6, CXCL8, MMP3 and CCL2 mRNA expression in relation to
untreated CT SF (n = 7) (*Wilcoxon test)
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Immunolabelling of synovial tissues
Immunohistochemical staining was performed using a
standard indirect avidin-biotin peroxidase method using
EnVision System-HRP Labelled Polymer (DAKO, Car-
pinteria, CA, USA). The following antibodies and
matched isotype controls were used: anti-CDKN2A/
p16INK4a (EPR1473 IgG clone, Abcam, Cambridge, UK)
and anti-NANOG mAb (D73G4 IgG clone, Cell Signal-
ing). Pretreatment included microwave heating for 15
min in Tris EDTA Tween 20 pH 9. One representative
section for each synovial tissue was photographed and
digitalized using a Zeiss Axiocam ERc5s camera and Zen
2012 software (Zeiss, Jena, Germany) on a Zeiss Axio
Scope.A1 microscope and the number of p16 and
NANOG positive cells per synovium area (mm2) was
quantified.
Double hsp47 (anti-hsp47 mAb M16.10A1 IgG2b clone,
Assay Designs, Ann Arbor, MI, USA) or CD68 (anti-
CD68 mAb KP1 IgG1 clone, DAKO) and p16 labelling by
IF was also performed using sequential incubation with
anti-goat IgG Alexa-Fluor 594 (red) and anti-mouse IgG1
Alexa-Fluor 488 (green) secondary antibodies (Invitrogen
Molecular Probes, Eugene, OR, USA) respectively.
Sections were counterstained with haematoxylin or 4′,
6-diamidino-2-phenylindole (DAPI) as indicated.
SF cultures
SF cultures were established by explant growth of small
biopsy fragments in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat inactivated fetal
bovine serum (FBS) (Lonza, Verviers, Belgium) and used
after 3rd passage.
For a model of stress-induced senescence, SF (5000
cells/cm2) were cultured for a total of 14 days and
treated with a short course of oxidative stress with H2O2
(200 μM) (Sigma-Aldrich, Madrid, Spain) for 1 h on day
5, or exposure to TNFα (100 ng/ml) (PreproTech, Rocky
Hill, NJ, USA) for 72 h on day 2. Medium was chan-
ged every other day and, on day 13, it was replaced
by 0.5% FBS. RNA and culture supernatants were col-
lected to analyze senescence and SASP mediators.
Aditionally, 14-days-cultured SF were treated with
fenobribrate (25 μM, 72 h) (Secalip™, Lacer SA, Spain)
or TNFα (20 ng/ml, 24 h).
Cell cycle analysis
SF (n = 3) were seeded in a density of 5000 cells/cm2
and grown for 14 days. After trypsinization SF were fixed
with cold ethanol 70% and stained with propidium iod-
ide (20 pg/ml) in presence of RNase A (Roche, Brand-
ford, USA) 100 μg/ml at 37 °C for 30 min [42]. Finally,
SF were analyzed by flow cytometry on a BD FACSCali-
bur instrument (Becton Dickinson, San José, CA, USA).
Senescence-associated beta-galactosidase (SA-β-gal)
assay
Quantification of senescence SF in cultures was deter-
mined by SA-β-gal assay. The assay was performed as
described Debacq-Chainiaux et al [25]. Cells nuclei were
counterstained with DAPI. Three to five random fields
for each condition were photographed and digitalized by
a Nikon Eclipse TE 2000-S microscope using the 100x
objective. The total number of SF in the cultures was
quantified by DAPI(+) nucleus using ImageJ software
(http://rsb.info.nih.gov/ij), and percentage of senescent
SA-β-gal(+) SF was determined.
Fig. 5 Response to an acute inflammatory damage of TNFα-induced
senescent SF. 14-day senescent (SEN) and control (CT) SF were
treated with TNFα. Untreated CT was used as reference. a Change in
IL6, CXCL8, MMP3 and CCL2 mRNA expression (n = 9). b Change in IL-
6 and IL-8 protein levels (n = 6). (*Wilcoxon test)
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Quantitative real time-PCR (qRT-PCR) analyses
Total RNA was extracted using TRI Reagent (Invitrogen)
according to the manufacturer’s protocol. For the quan-
tification of mRNA, 1μg was used for first strand cDNA
synthesis with High Capacity cDNA Transcription Kit
(Applied Biosystems, Foster City, CA, USA).
For PCR amplification we used cDNA and primers added
to Power Sybr Green PCR Master Mix (Applied Biosys-
tems). The sequences of PCR primers used are listed in add-
itional table (see Additional file 3: Table S1). β-ACTIN was
used as an endogenous reference. qRT-PCRs were per-
formed on an Applied Biosystems 7500 Fast Real-Time PCR
System (Applied Biosystems). For relative quantification we
compared the amount of target normalized to the endogen-
ous reference using 2-ΔΔCt formula (Ct = threshold cycle).
Enzyme-linked immunosorbent assay (ELISA)
Measurement of IL-6 and IL-8 in culture supernatants
were determined by single specific ELISA (Biolegend
Inc., San Diego, CA, USA) according to the manufac-
turer protocols. The read-out for all ELISAs was carried
out with a MultiskanEX plate reader (ThermoScientific).
Statistical analysis
Data were analyzed using GraphPad Prism software v6.0
(GraphPad Software, San Diego, CA, USA). Correlation
was analysed by Pearson’s test. Means were compared by
one-way ANOVA with Holm-Sidak’s post hoc test, Fried-
man test with Dunn’s multiple comparisons, Mann-
Whitney test or Wilcoxon test as appropriate. A p value <
0.05 was considered statistically significant (*p < 0.05, **p <
0.01, ***p < 0.001).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12979-019-0169-4.
Additional file 1: Figure S1. Double hsp47/p16 and CD68/p16
labelling of synovial tissues. Representative images of synovial tissues
labelled for hsp47 and CD68 (red), p16 (green) and merge. Arrows
indicate senescent double positive cells for each label.
Additional file 2: Figure S2. Kinetics of IL6 and CXCL8 mRNA
expression in senescent SF. SF were culture for 14 days and subjected to
TNFα-induced senescence. Graphics show IL6 and CXCL8 mRNA levels in
senescent (SEN) and control (CT) SF at the indicated time-points (n = 2).
Additional file 3: Table S1. Primer sequences used for quantitative
real-time PCR analysis.
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